Buffington Mohr McNeal’s Exact Sciences EXAS Stock Holding History

Buffington Mohr McNeal’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-350	Closed	-$30K	–	183
2019 Q1	$30K	Buy	+350	New	+$29.8K	0.01%	210

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Buffington Mohr McNeal's EXAS Position: Q2 2019 in Review

Buffington Mohr McNeal sold out of Exact Sciences (EXAS) in Q2 2019, closing a stake of 350 shares — an estimated $30K sold.

Buffington Mohr McNeal first reported a position in EXAS in Q1 2019 and held it in 1 quarter. The position peaked at $30K in Q1 2019. 472 funds tracked by Wall St. Rank hold EXAS as of Q2 2019.

Buffington Mohr McNeal reported no remaining Exact Sciences position as of Q2 2019 after selling out during the quarter.
Buffington Mohr McNeal sold 350 Exact Sciences shares in Q2 2019, an estimated $30K.
Buffington Mohr McNeal first reported a position in Exact Sciences in Q1 2019 and held it in 1 quarter.
Buffington Mohr McNeal's Exact Sciences position peaked at $30K in Q1 2019.
472 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2019.

Based on Buffington Mohr McNeal's 13F filing for Q2 2019, filed 31 Jul 2019.